PT  - JOURNAL ARTICLE
AU  - Eklund, Rakel
AU  - Eisma, Maarten C.
AU  - Boelen, Paul A.
AU  - Arnberg, Filip
AU  - Sveen, Josefin
TI  - A Mobile App for Prolonged Grief among Bereaved Parents: Study Protocol for a Randomized Controlled Trial
AID  - 10.1101/2021.04.23.21256003
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.04.23.21256003
4099  - http://medrxiv.org/content/early/2021/04/26/2021.04.23.21256003.short
4100  - http://medrxiv.org/content/early/2021/04/26/2021.04.23.21256003.full
AB  - Introduction Bereaved parents have elevated risk to develop mental health problems, yet, few studies have evaluated the effect of psychosocial interventions developed for bereaved parents. Cognitive behavioral therapy (CBT), both face-to-face or digitally delivered, has shown to be an effective intervention for prolonged grief symptoms. Self-help mobile apps offer various advantages and studies show improved mental health after app interventions. No app has yet been evaluated targeting prolonged grief in bereaved parents. Therefore, the aim of this planned study is to develop and examine the effectiveness of a CBT-based mobile app, called My Grief, in reducing symptoms of prolonged grief, as well as other psychological symptoms, in bereaved parents. Another aim is to assess users’ experiences and adverse events of My Grief.Methods and analysis We will conduct a two-armed randomized waitlist-controlled trial. Parents living in Sweden, who lost a child to cancer between one and ten years ago, with elevated symptoms of prolonged grief, will be recruited to participate in the trial. The content of My Grief covers four main domains (Learn; Self-monitoring; Exercises; Get support) and builds on principles of CBT and the proven-effective PTSD Coach app. Participants in the intervention group will fill out online questionnaires at baseline and at 3-, 6- and 12-months follow-ups, and the waitlist-controls at baseline and at 3 months. The primary outcome will be prolonged grief symptoms at the 3 months follow-up. Secondary outcomes are posttraumatic stress and depression symptoms, quality of life, and cognitive behavioral variables (i.e., avoidance, rumination, negative cognitions).Ethics and dissemination Ethical approval has been received from the Swedish Ethical Review Authority (project no. 2021-00770). If the app is shown to be effective, the app will be made publicly accessible on app stores, so that it can benefit other bereaved parents.Trial registration Clinicaltrials.gov, identifier: NCT04552717.STRENGTHS AND LIMITATIONSThis is the first study to examine whether access of a self-help app can have beneficial effect on bereaved parent’s mental health, quality of lifeThis study will examine the effect of the app on cognitive-behavioral processes proposed to underlie the development of prolonged grief.Generalizability of findings from this study may be limited as parents who want to participate in such study may experience fewer barriers to talk about the loss and seek help for their grief.This study includes parents who have lost a child to cancer, hence the findings may not be generalizable to other causes.This study uses self-report questionnaires, hence we do not establish formal diagnosis of prolonged grief disorder.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT04552717Funding StatementThis research was funded by the Swedish Childhood Cancer Fund (PR2018-0047; TJ2018-0002). This funding source had no role in the design of this study and will not have any role during its execution, analyses, interpretation of the data, or decision to submit results.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval has been received from the Swedish Ethical Review Authority (project no. 2021-00770).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be available upon request to the principal investigator (JS) and unidentifiable data from this trial will be stored in data repositories at www.OSF.io.